de WardenerHEMillsIHClaphamWFStudies on the afferent mechanism of the sodium diuresis which follows the administration of intravenous saline in the dog. Clin Sci1961; 21: 249–58.
2.
BahlmannJSMcDonaldJVentomMGThe effect on urinary sodium excretion of blood volume expansion without changing the composition of the blood. Clin Sci1967; 32: 403–13.
3.
de WardenerHE. Natriuretic hormone. Clin Sci Mol Med1977; 53: 1–8.
4.
SonnenbergHVeressATPearceJW. A humoral component of the natriuretic mechanism in sustained blood volume expansion. J Clin Invest1972; 51: 2631–44.
5.
KnockCAde WardenerHE. Evidence in vivo for circulating natriuretic substance in rats after expanding the blood volume. Clin Sci1980; 59: 411–21.
6.
PearceJWSonnenbergHVeressATEvidence for a humoral factor modifying the renal response to blood volume expansion in the rat. Can J Physiol Pharmacol1969; 47: 377–86.
7.
LichardusBPliskaVUhrinVThe cow as a model for investigating natriuretic activity. Lancet1968; i: 127–9.
8.
NutbourneDMThe effect of expanding the blood volume of a dog on the short circuit current across an isolated frog skin incorporated in the dog's circulation. Clin Sci1970; 38: 629–48.
9.
ClarksonEMTalnerLBde WardenerHE. The effect of plasma from blood volume expanded dogs on sodium, potassium and PAH transport of renal tubule fragments. Clin Sci1970; 38: 617–27.
10.
GonickHCKramerHJPaulWCirculating inhibitor of sodium-potassium-activated adenosine triphosphate after expansion of extracellular fluid volume in rats. Clin Sci Molec Med1977; 53: 329–34.
11.
PostonLWilkinsonSPSewellRInhibition of leucocyte sodium transport during mineralocorticoid ‘escape’. Clin Sci1980; 58: 90.
12.
FlierJSMaratos-FlierEPallottaJAEndogenous digitalis-like activity in the plasma of the toad Bufo marinus. Nature1979; 279: 341–43.
13.
GruberKAWhitakerJMBuckalewVMJrEndogenous digitalis-like substance in plasma of volume expanded dogs. Nature1980; 287: 743–5.
14.
de WardenerHEMacGregorGAClarksonEMEffect of sodium intake on ability of human plasma to inhibit renal Na+-K+-Adenosine triphosphatase in vitro. Lancet1981; i: 411–12.
15.
FentonSClarksonEMMacGregorGA. Alaghband-Zadeh J, de Wardener HE. An assay of the capacity of biological fluids to stimulate renal glucose-6-phosphate dehydrogenase (G6PD) activity in vitro as a marker of their ability to inhibit sodium-potassium dependent adenosive triphosphatase (Na+-K+-ATPase) activity. J. Endocrinol1982 in press.
16.
ClarksonEMRawSMde WardenerHE. Further observations on a low molecular weight natriuretic substance in the urine of normal man. Kidney Internal1979; 16: 710–21.
17.
LeeJde WardenerHE. Neurosecretion and sodium excretion. Kidney Internal1974; 6: 323–30.
18.
KaloyanidesGJCohenLDiBonaGF. Failure of selected endocrine organ ablation to modify the natriuresis of blood volume expansion in the dog. Clin Sci Molec Med1977; 52: 351–6.
19.
ClarksonEMKoutsaimanisKGDavidmanMThe effect of brain extracts on urinary sodium excretion of the rat and the intracellular sodium concentration of renal tubule fragments. Clin Sci Molec Med1974; 47: 201–13.
20.
Silva-NettoCRde Mello AiresMMalnicG. Hypothalamic stimulation and electrolyte excretion: A micropuncture study. Am J Physiol1980; 239: F206–F214.
21.
HaupertGISauchoJM. Sodium transport inhibitor from bovine hypothalamus. Proc Nat Acad Sci, USA1979; 76: 4658–60.
22.
LichsteinDSamueloyS. Endogenous ‘ouabain-like’ activity in rat brain. Biochem Biophys Res Comm1980; 96: 1518–23.
BlausteinMP. Sodium ions, calcium ions, blood pressure regulation and hypertension: A reassessment of a hypothesis. Am J Physiol1977; 232: C165–C173.
25.
de WardenerHEMacGregorGA. Dahl's hypothesis that a saluretic substance may be responsible for a sustained rise in arterial pressure: Its possible role in essential hypertension. Kidney Internal1980; 18: 1–9.
26.
PostonLEvidence for a circulating sodium transport inhibitor in essential hypertension. Br Med J in press.
27.
MacGregorGAFentonSAlaghband-ZadehJMarkanduNRoulstonJEde WardenerHE. Evidence for a raised concentration of a circulating sodium transport inhibitor in essential hypertension. Br Med J. 1981283: 1355–7.